# DURABILITY-200: EverFlex 200mm Long Nitinol Stents in TASC C&D Femoropopliteal Lesions

> **NCT00637741** · PHASE4 · COMPLETED · sponsor: **Flanders Medical Research Program** · enrollment: 100 (actual)

## Conditions studied

- Peripheral Vascular Disease
- Intermittent Claudication
- Critical Limb Ischemia

## Interventions

- **DEVICE:** Everflex 200

## Key facts

- **NCT ID:** NCT00637741
- **Lead sponsor:** Flanders Medical Research Program
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-09
- **Final completion:** 2010-11
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2010-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00637741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00637741, "DURABILITY-200: EverFlex 200mm Long Nitinol Stents in TASC C&D Femoropopliteal Lesions". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00637741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*